UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1653-1659

2009

Volltextzugriff (PDF)

Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)

American journal of clinical oncology, 2007-02, Vol.30 (1), p.45-50

2007

Volltextzugriff (PDF)

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3793-3803

1999

Volltextzugriff (PDF)

Use of Molecular Imaging to Predict Clinical Outcome in Patients With Rectal Cancer After Preoperative Chemotherapy and Radiation

International journal of radiation oncology, biology, physics, 2009-05, Vol.74 (1), p.55-59

2009

Volltextzugriff (PDF)

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Critical reviews in oncology/hematology, 2001-07, Vol.39 (1), p.181-194

2001

Volltextzugriff (PDF)

Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

Cancer, 2002-02, Vol.94 (S4), p.1349-1357

2002

Volltextzugriff (PDF)

The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial

Clinical cancer research, 2009-10, Vol.15 (20), p.6462-6471

2009

Volltextzugriff (PDF)

PET scan assessment of chemotherapy response in metastatic paraganglioma

American journal of clinical oncology, 2003-12, Vol.26 (6), p.563-566

2003

Volltextzugriff (PDF)

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation

Leukemia & lymphoma, 2013-03, Vol.54 (3), p.497-502

2013

Volltextzugriff (PDF)

A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer

American journal of clinical oncology, 2010-02, Vol.33 (1), p.89-93

2010

Volltextzugriff (PDF)

Follow-Up Results of a Phase II Study of Ibritumomab Tiuxetan Radioimmunotherapy in Patients with Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Cancer biotherapy & radiopharmaceuticals, 2004-08, Vol.19 (4), p.478-481

2004

Volltextzugriff (PDF)

Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma

Seminars in oncology, 2002-02, Vol.29 (1S2), p.87

2002

Volltextzugriff (PDF)

Effects of hyperthermia and iodine‐131 labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice

Cancer, 1992-12, Vol.70 (12), p.2785-2791

1992

Volltextzugriff (PDF)

A new radioisotope technique of splenic localization for radiation treatment

International journal of radiation oncology, biology, physics, 1988-07, Vol.15 (1), p.221-222

1988

Volltextzugriff (PDF)

A phase I escalating-dose safety, dosimetry and efficacy study of radiolabeled monoclonal antibody LYM-1

Cancer biotherapy, 1993, Vol.8 (1), p.3-16

1993

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Use of Molecular Imaging to Predict Clinical Outcome in Patients With Rectal Cancer After Preoperative Chemotherapy and Radiation

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial

PET scan assessment of chemotherapy response in metastatic paraganglioma

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation

A prospective trial comparing lymphangiogram, cross-sectional imaging, and positron emission tomography scan in the detection of lymph node metastasis in locally advanced cervical cancer

Follow-Up Results of a Phase II Study of Ibritumomab Tiuxetan Radioimmunotherapy in Patients with Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin's Lymphoma and Mild Thrombocytopenia

Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma

Effects of hyperthermia and iodine‐131 labeled anticarcinoembryonic antigen monoclonal antibody on human tumor xenografts in nude mice

A new radioisotope technique of splenic localization for radiation treatment

A phase I escalating-dose safety, dosimetry and efficacy study of radiolabeled monoclonal antibody LYM-1

Aktive Filter

Suchergebnisse filtern